Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MDL 899

Known as: MDL-899 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
MDL-899 is new phthalazine derivative which has been developed as a substitute for hydralazine, which has several undesirable… Expand
1986
1986
The effects of N-(2,5-dimethyl-1H-pyrrol-1-yl)6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899) on systemic, pulmonary… Expand
1985
1985
N-(2,5-Dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899) is a new long-acting antihypertensive… Expand
1985
1985
The pharmacokinetics of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new… Expand
1985
1985
Summary: In this study of 10 patients with essential hypertension inadequately controlled by standard β-blocker–diuretic… Expand
1983
1983
Summary We conducted pharmacodynamic studies with a new vasodilator, MDL-899. Following initial dose-ranging studies we studied… Expand